Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation

Clinical trial NCT07226557 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07226557
Sponsor: National Institutes of Health Clinical Center (CC)
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Carbapenem Resistant Bacterial Infection Acinetobacter Baumannii Infection Antimicrobial Drug Resistance

Start date: 2025-01-01
Primary completion: 2025-12-31
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.